These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 27918874

  • 1. Effects of the Natural β-Carboline Alkaloid Harmine, a Main Constituent of Ayahuasca, in Memory and in the Hippocampus: A Systematic Literature Review of Preclinical Studies.
    Dos Santos RG, Hallak JE.
    J Psychoactive Drugs; 2017; 49(1):1-10. PubMed ID: 27918874
    [Abstract] [Full Text] [Related]

  • 2. Behavioral profile of constituents in ayahuasca, an Amazonian psychoactive plant mixture.
    Freedland CS, Mansbach RS.
    Drug Alcohol Depend; 1999 May 03; 54(3):183-94. PubMed ID: 10372792
    [Abstract] [Full Text] [Related]

  • 3. Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and Humans.
    Nunes AA, Dos Santos RG, Osório FL, Sanches RF, Crippa JA, Hallak JE.
    J Psychoactive Drugs; 2016 May 03; 48(3):195-205. PubMed ID: 27230395
    [Abstract] [Full Text] [Related]

  • 4. The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro.
    Morales-García JA, de la Fuente Revenga M, Alonso-Gil S, Rodríguez-Franco MI, Feilding A, Perez-Castillo A, Riba J.
    Sci Rep; 2017 Jul 13; 7(1):5309. PubMed ID: 28706205
    [Abstract] [Full Text] [Related]

  • 5. Mutagenicity of Ayahuasca and Their Constituents to the Salmonella/Microsome Assay.
    Kummrow F, Maselli BS, Lanaro R, Costa JL, Umbuzeiro GA, Linardi A.
    Environ Mol Mutagen; 2019 Apr 13; 60(3):269-276. PubMed ID: 30488498
    [Abstract] [Full Text] [Related]

  • 6. Cerebroprotective effect of isolated harmine alkaloids extracts of seeds of Peganum harmala L. on sodium nitrite-induced hypoxia and ethanol-induced neurodegeneration in young mice.
    Biradar SM, Joshi H, Tarak KC.
    Pak J Biol Sci; 2013 Dec 01; 16(23):1687-97. PubMed ID: 24506035
    [Abstract] [Full Text] [Related]

  • 7. Developments in harmine pharmacology--implications for ayahuasca use and drug-dependence treatment.
    Brierley DI, Davidson C.
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec 03; 39(2):263-72. PubMed ID: 22691716
    [Abstract] [Full Text] [Related]

  • 8. Unraveling the mechanistic interplay of mediators orchestrating the neuroprotective potential of harmine.
    Kadyan P, Singh L.
    Pharmacol Rep; 2024 Aug 03; 76(4):665-678. PubMed ID: 38758470
    [Abstract] [Full Text] [Related]

  • 9. Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.
    Riba J, McIlhenny EH, Valle M, Bouso JC, Barker SA.
    Drug Test Anal; 2012 Aug 03; 4(7-8):610-6. PubMed ID: 22514127
    [Abstract] [Full Text] [Related]

  • 10. Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics.
    Riba J, Valle M, Urbano G, Yritia M, Morte A, Barbanoj MJ.
    J Pharmacol Exp Ther; 2003 Jul 03; 306(1):73-83. PubMed ID: 12660312
    [Abstract] [Full Text] [Related]

  • 11. Immunological Modulation and Control of Parasitaemia by Ayahuasca Compounds: Therapeutic Potential for Chagas's Disease.
    Katchborian-Neto A, Santos MFC, Vilas-Boas DF, Dos Santos EG, Veloso MP, Bueno PCP, Caldas IS, Soares MG, Dias DF, Chagas-Paula DA.
    Chem Biodivers; 2022 Oct 03; 19(10):e202200409. PubMed ID: 36163588
    [Abstract] [Full Text] [Related]

  • 12. Neuroprotective potential of Ayahuasca and untargeted metabolomics analyses: applicability to Parkinson's disease.
    Katchborian-Neto A, Santos WT, Nicácio KJ, Corrêa JOA, Murgu M, Martins TMM, Gomes DA, Goes AM, Soares MG, Dias DF, Chagas-Paula DA, Paula ACC.
    J Ethnopharmacol; 2020 Jun 12; 255():112743. PubMed ID: 32171895
    [Abstract] [Full Text] [Related]

  • 13. The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging.
    Dos Santos RG, Balthazar FM, Bouso JC, Hallak JE.
    J Psychopharmacol; 2016 Dec 12; 30(12):1230-1247. PubMed ID: 27287824
    [Abstract] [Full Text] [Related]

  • 14. A rapid and simple method for the determination of psychoactive alkaloids by CE-UV: application to Peganum Harmala seed infusions.
    Tascón M, Benavente F, Vizioli NM, Gagliardi LG.
    Drug Test Anal; 2017 Apr 12; 9(4):596-602. PubMed ID: 27377797
    [Abstract] [Full Text] [Related]

  • 15. Effects of Long-Term Ayahuasca Administration on Memory and Anxiety in Rats.
    Favaro VM, Yonamine M, Soares JC, Oliveira MG.
    PLoS One; 2015 Apr 12; 10(12):e0145840. PubMed ID: 26716991
    [Abstract] [Full Text] [Related]

  • 16. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.
    Hamill J, Hallak J, Dursun SM, Baker G.
    Curr Neuropharmacol; 2019 Apr 12; 17(2):108-128. PubMed ID: 29366418
    [Abstract] [Full Text] [Related]

  • 17. Effects of harmine, an acetylcholinesterase inhibitor, on spatial learning and memory of APP/PS1 transgenic mice and scopolamine-induced memory impairment mice.
    He D, Wu H, Wei Y, Liu W, Huang F, Shi H, Zhang B, Wu X, Wang C.
    Eur J Pharmacol; 2015 Dec 05; 768():96-107. PubMed ID: 26526348
    [Abstract] [Full Text] [Related]

  • 18. Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca.
    McKenna DJ, Towers GH, Abbott F.
    J Ethnopharmacol; 1984 Apr 05; 10(2):195-223. PubMed ID: 6587171
    [Abstract] [Full Text] [Related]

  • 19. Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015.
    Heise CW, Brooks DE.
    J Med Toxicol; 2017 Sep 05; 13(3):245-248. PubMed ID: 27896660
    [Abstract] [Full Text] [Related]

  • 20. Treatment with harmine ameliorates functional impairment and neuronal death following traumatic brain injury.
    Zhong Z, Tao Y, Yang H.
    Mol Med Rep; 2015 Dec 05; 12(6):7985-91. PubMed ID: 26496827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.